Table: RaQualia Pharma - 6-MTH group results
Aug 10 (Reuters)-
RaQualia Pharma Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2017 Jun 30, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 463 mln 1.18
Operating loss 352 mln loss 791 mln
Recurring loss 300 mln loss 777 mln
Net loss 287 mln loss 778 mln
EPS loss 14.99 yen loss 40.45 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T
((Tokyo Headline News Desk +813 6441 1812))